EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Stable human brain microvascular endothelial cell line retaining its barrier‐specific nature independent of the passage number

Yasuteru Sano, Yoko Kashiwamura, Masaaki Abe, Le‐Ha Dieu, Jörg Huwyler, Fumitaka Shimizu, Hiroyo Haruki, Toshihiko Maeda, Kazuyuki Saito, Ayako Tasaki, Takashi Kanda

Clinical and Experimental Neuroimmunology · 2013

DOI: 10.1111/cen3.12001 ↗
AbstractBibliografische Angaben

Abstract

Abstract Objectives The breakdown of the blood–brain barrier ( BBB ) has been considered to be a key step in the disease process of a number of neuroimmunological disorders. Although several in vitro BBB models derived from human tissues have been established, no human conditionally immortalized in vitro BBB models using a temperature‐sensitive SV 40‐ T antigen ( ts A 58 ) and human telomerase reverse transcriptase ( h TERT ) have ever been reported. In the present study, we established a new human brain microvascular endothelial cell line harboring ts A 58 and h TERT genes, and extensively characterized this new model. Methods TY 08 cells, derived from the human BBB and harboring ts A 58 , were infected with retroviruses possessing h TERT genes. We examined whether this new model retains its barrier‐specific nature, independent of the passage number. Results The obtained endothelial cell line, termed TY 09, proliferated well under the permissive temperature and stopped growing under the non‐permissive temperature, despite the acquisition of h TERT as an additional immortalizing gene. Even with a high‐passage number, the cells maintained a spindle‐shaped morphology, the expression of the von W illebrand factor, tight junction proteins and transporters. Furthermore, we carried out a transendothelial transport study for TY 09 cells and h CMEC / D 3 cells, thereby proving that both cell lines have almost the same nature with respect to transcellular permeability of various hydrophilic and hydrophobic substances. Conclusions The new stable conditionally immortalized TY 09 cells, retaining the in vivo BBB functions, should facilitate the performance of future studies for determining the pathophysiology of various neuroimmunological diseases.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →